(Q35570990)

8 August 2017

1 reference

title

Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer (English)

1 reference

8 August 2017

1 reference

Koji Kawai

1

1 reference

8 August 2017

Hideyuki Akaza

2

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

http://www.tandfonline.com/doi/pdf/10.1517/14740338.2.6.587

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Expert Opinion on Drug Safety

26 March 2024

published in

1 reference

8 August 2017

volume

2

1 reference

8 August 2017

issue

6

1 reference

8 August 2017

page(s)

587-596

1 reference

Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Nodular form of bleomycin-related pulmonary injury in patients with osteogenic sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

A clinical review of bleomycin--a new antineoplastic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Fatal bleomycin pulmonary toxicity in the west of Scotland 1991-95: a review of patients with germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Factors influencing postoperative morbidity and mortality in patients treated with bleomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Oxygen-Exacerbated Bleomycin Pulmonary Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Pulmonary Toxicity of Antineoplastic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Pulmonary drug toxicity: radiologic and pathologic manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Detecting bleomycin pulmonary toxicity: a continued conundrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Curing metastatic testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Increased DNA chain breakage by combined action of bleomycin and superoxide radical

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

C-C chemokines: novel mediators of the profibrotic inflammatory response to bleomycin challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

PRECAPILLARY SYSTEMIC-PULMONARY ANASTOMOSES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Chemokine receptors in airway disease: which receptors to target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Stimulation of rat endothelial cell transforming growth factor-beta production by bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.6.587

Bleomycin Treatment of the Tumors of Penis and Scrotum

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients

26 March 2024

4

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Chemotherapy-induced eosinophilic pneumonia. Relation to bleomycin

26 March 2024

8

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Pulmonary complications associated with combination chemotherapy programs containing bleomycin

26 March 2024

10

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Serum creatinine level during chemotherapy for testicular cancer as a possible predictor of bleomycin-induced pulmonary toxicity

26 March 2024

18

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Risk Factors of Anesthesia and Surgery in Bleomycin-Treated Patients

26 March 2024

21

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Pulmonary toxicity in patients with advanced-stage germ cell tumors receiving bleomycin with and without granulocyte colony stimulating factor

26 March 2024

26

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Bleomycin causes alveolar macrophages from cigarette smokers to release hydrogen peroxide

26 March 2024

28

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Acute chest pain syndrome during bleomycin infusions

26 March 2024

31

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Pulmonary complications of chemotherapy regimens containing bleomycin

26 March 2024

33

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Bleomycin toxicity simulating metastatic nodules to the lungs

26 March 2024

34

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Bleomycin-induced nodular pulmonary fibrosis masquerading as metastatic testicular cancer

26 March 2024

35

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

26 March 2024

36

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease

26 March 2024

39

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Bleomycin-induced pulmonary function abnormalities

26 March 2024

41

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

26 March 2024

44

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial

26 March 2024

46

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group

26 March 2024

47

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Bleomycin in germ cell tumor therapy: not all regimens are created equal

26 March 2024

50

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study

26 March 2024

51

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

The effect of corticosteroid administration on bleomycin lung toxicity

26 March 2024

52

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Contribution of T lymphocytes to the development of bleomycin-induced pulmonary fibrosis

26 March 2024

57

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

The effect of an anti-CD3 monoclonal antibody on bleomycin-induced lymphokine production and lung injury

26 March 2024

58

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

T cell independence of bleomycin-induced pulmonary fibrosis

26 March 2024

59

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Bleomycin cytotoxicity is prevented by superoxide dismutase in vitro

26 March 2024

62

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice

26 March 2024

63

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Pulmonary fibrosis: pathways are slowly coming into light

26 March 2024

66

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Lung cytokine production in bleomycin-induced pulmonary fibrosis

26 March 2024

68

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica

26 March 2024

70

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Resistance of TNF/LT alpha double deficient mice to bleomycin-induced fibrosis

26 March 2024

74

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Repression of bleomycin-induced pneumopathy by TNF

26 March 2024

75

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Spontaneous in vitro release of alveolar-macrophage cytokines after the intratracheal instillation of bleomycin in rats. Characterization and kinetic studies

26 March 2024

76

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin

26 March 2024

83

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycin-induced pulmonary fibrosis

26 March 2024

85

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung

26 March 2024

90

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Morphologic and morphometric evaluation of the effect of ICRF-187 on bleomycin-induced pulmonary toxicity

26 March 2024

92

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Amelioration of bleomycin-induced pulmonary injury by cyclosporin A

26 March 2024

94

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Comparative study on effects of pentoxifylline, prednisolone and colchicine in experimental alveolitis

26 March 2024

95

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Effect of immunomodulators on bleomycin-induced lung injury

26 March 2024

96

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Bleomycin-induced lung toxicity and pentoxifylline

26 March 2024

97

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor

26 March 2024

98

1 reference

https://api.crossref.org/works/10.1517/14740338.2.6.587

26 March 2024

Identifiers

1 reference

8 August 2017

1 reference